Donald Frail is Director of Pandion Therapeutics, Inc.. Currently has a direct ownership of 0 shares of PAND, which is worth approximately $0. The most recent transaction as insider was on Apr 01, 2021, when has been sold 61,113 shares (Common Stock) at a price of $60.0 per share, resulting in proceeds of $3,666,780. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Donald Frail Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2021
SELL
Disposition due to a tender of shares in a change of control transaction
$3,666,780 $60.0 p/Share
61,113 Reduced 100.0%
0 Common Stock
DF

Donald Frail

Director
Watertown, MA

Track Institutional and Insider Activities on PAND

Follow Pandion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PAND shares.

Notify only if

Insider Trading

Get notified when an Pandion Therapeutics, Inc. insider buys or sells PAND shares.

Notify only if

News

Receive news related to Pandion Therapeutics, Inc.

Track Activities on PAND